These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 1629385)

  • 1. Haloperidol and reduced haloperidol in saliva and blood.
    Dysken MW; Johnson SB; Holden L; Kuskowski M; Ofstehage J; Skare S; Vatassery G
    J Clin Psychopharmacol; 1992 Jun; 12(3):186-90. PubMed ID: 1629385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haloperidol decanoate pharmacokinetics in red blood cells and plasma.
    Dysken MW; Kim SW; Vatassery G; Johnson SB; Skare S; Holden L; Thomsyck L
    J Clin Psychopharmacol; 1992 Apr; 12(2):128-32. PubMed ID: 1573034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloperidol metabolism in psychiatric patients: importance of glucuronidation and carbonyl reduction.
    Someya T; Shibasaki M; Noguchi T; Takahashi S; Inaba T
    J Clin Psychopharmacol; 1992 Jun; 12(3):169-74. PubMed ID: 1629382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of haloperidol levels between saliva and plasma of acutely ill schizophrenic patients.
    Jain T; Bhandari A; Ram V; Sharma S; Parakh M; Parakh MC
    Clin Biochem; 2011 Jun; 44(8-9):675-80. PubMed ID: 21458435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cefotiam in plasma, parotid saliva and mixed saliva in healthy adults.
    Zerfowski M; Schlegel P; Maier H
    Arzneimittelforschung; 1991 Mar; 41(3):257-9. PubMed ID: 1867664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of haloperidol levels between submandibular saliva and brain in the rat.
    Takai N; Eto K; Uchihashi K; Yamaguchi M; Nishikawa Y
    Arch Oral Biol; 2006 Jul; 51(7):567-72. PubMed ID: 16426565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced haloperidol/haloperidol ratios after oral haloperidol and decanoate administration in schizophrenics.
    Chang WH; Lin SK; Juang DJ; Chen LC; Yang CH; Hu WH; Chien CP; Lam YF; Jann MW
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Jan; 17(1):105-12. PubMed ID: 8416597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Depot haloperidol treatment in outpatients with schizophrenia on monotherapy: impact of CYP2D6 polymorphism on pharmacokinetics and treatment outcome.
    Panagiotidis G; Arthur HW; Lindh JD; Dahl ML; Sjöqvist F
    Ther Drug Monit; 2007 Aug; 29(4):417-22. PubMed ID: 17667795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
    Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haloperidol and reduced haloperidol plasma levels in selected schizophrenic patients.
    Ereshefsky L; Davis CM; Harrington CA; Jann MW; Browning JL; Saklad SR; Burch NR
    J Clin Psychopharmacol; 1984 Jun; 4(3):138-42. PubMed ID: 6736273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
    Ulrich S; Sandmann U; Genz A
    Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgA subclasses in HIV disease: dichotomy between raised levels in serum and decreased secretion rates in saliva.
    Sweet SP; Rahman D; Challacombe SJ
    Immunology; 1995 Dec; 86(4):556-9. PubMed ID: 8567021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood levels of haloperidol and clinical outcome in schizophrenia.
    Doddi S; Rifkin A; Karajgi B; Cooper T; Borenstein M
    J Clin Psychopharmacol; 1994 Jun; 14(3):187-95. PubMed ID: 8027415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum haloperidol and neuroleptic receptor levels in chronic psychosis.
    Cannon DJ; McMillan DE; Newton JE; Fody EP; Metzer WS; Claybrook M; Couch L; Paige SR
    Ann Clin Lab Sci; 1988; 18(5):378-83. PubMed ID: 3178137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood levels of haloperidol in schizophrenic patients.
    Shvartsburd A; Dekirmenjian H; Smith RC
    J Clin Psychopharmacol; 1983 Feb; 3(1):7-12. PubMed ID: 6833528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haloperidol plasma and red blood cell levels and clinical antipsychotic response.
    Garver DL; Hirschowitz J; Glicksteen GA; Kanter DR; Mavroidis ML
    J Clin Psychopharmacol; 1984 Jun; 4(3):133-7. PubMed ID: 6736272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics and clinical evaluation of haloperidol decanoate loading dose regimen.
    Ereshefsky L; Saklad SR; Tran-Johnson T; Toney G; Lyman RC; Davis CM
    Psychopharmacol Bull; 1990; 26(1):108-14. PubMed ID: 2371365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between haloperidol plasma concentration, debrisoquine metabolic ratio, CYP2D6 and CYP2C9 genotypes in psychiatric patients.
    LLerena A; de la Rubia A; Berecz R; Dorado P
    Pharmacopsychiatry; 2004 Mar; 37(2):69-73. PubMed ID: 15048614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood levels of haloperidol and thioridazine during maintenance neuroleptic treatment of schizophrenic outpatients.
    Shvartsburd A; Sajadi C; Morton V; Mirabi M; Gordon J; Smith RC
    J Clin Psychopharmacol; 1984 Aug; 4(4):194-8. PubMed ID: 6470190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.